The global peptide therapeutics market is projected to experience robust growth, reaching a market value of US$ 85.9 billion by 2031, driven by factors such as the rising prevalence of chronic diseases, advancements in peptide synthesis and delivery technologies, and increasing investments in biopharmaceutical research and development. This market analysis explores the key drivers, trends, and regional insights shaping the future of peptide therapeutics.